Edinburgh-based healthcare software firm Craneware has reported a 10% increase in revenue, reaching $100 million for the six months ending 31 December 2024, up from $91.2 million the previous year.
The company’s unaudited first-half results also showed a 10% rise in adjusted earnings before tax, increasing from $27.5 million to $30.3 million.
Strong Profit Growth and Dividend Boost
Craneware’s adjusted pre-tax profit saw an even greater increase, rising by 21% year-on-year to $20.6 million. In response, the company has announced a 4% increase in its dividend, bringing it to 13.5 pence per share.
The company also reported an 18% rise in adjusted basic earnings per share, alongside improved operating cash conversion. This resulted in cash reserves growing from $63.9 million to $72.2 million, while bank debt was reduced from $59.2 million to $31.6 million.
Market Position and Future Growth
Craneware’s board remains confident in its full-year outlook, expecting results for the financial year ending 30 June 2025 to align with market expectations. Longer term, the company sees significant growth potential due to its strong market positioning and expanding footprint within the US healthcare sector.
Chief Executive Keith Neilson highlighted the company’s momentum, stating:
“Our trusted position at the heart of the US healthcare market is translating into double-digit growth rates, as we support our customers in transforming their operations and finances through our software and data-driven insights.”
He added that post-election stability in the US healthcare sector is leading hospitals to focus on strategic growth, creating a sustained demand for Craneware’s offerings.
“The continued expansion of our Trisus platform, increasing engagement from major players within the US healthcare market, and our strong financial foundations mean we are well-placed to execute on our ambitious growth strategy.”
With its strong financial position and increasing customer engagement, Craneware remains focused on driving further expansion and innovation within the healthcare technology sector.
